IL-2 fusion polypeptides, Alkermes Pharma Ireland, patent
Summary
IL-2 fusion polypeptides, Alkermes Pharma Ireland, patent
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
IL-2 FUSION POLYPEPTIDE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
Publication EP4149514A1 Kind: A1 Mar 25, 2026
Applicants
Alkermes Pharma Ireland Limited
Inventors
GBORMITTAH, Francisca O., ZEIDAN, Tarek A.
IPC Classifications
A61K 38/20 20060101AFI20240517BHEP A61P 35/00 20060101ALI20240517BHEP A61K 9/19 20060101ALI20240517BHEP A61K 47/12 20060101ALI20240517BHEP A61K 47/26 20060101ALI20240517BHEP A61K 9/08 20060101ALI20240517BHEP C07K 14/55 20060101ALI20240517BHEP C07K 14/715 20060101ALI20240517BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for ChangeBridge: EPO Bulletin - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Peptides (C07K) publishes new changes.